A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

BACKGROUND: In a phase III clinical trial, CheckMate 025, treatment of metastatic renal cell carcinoma (mRCC) with nivolumab demonstrated superior efficacy over everolimus. However, as the clinical trial excluded patients with specific complications and poor performance status (PS), the effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinata, Nobuyuki, Yonese, Junji, Masui, Satoru, Nakai, Yasutomo, Shirotake, Suguru, Tatsugami, Katsunori, Inamoto, Teruo, Nozawa, Masahiro, Ueda, Kosuke, Etsunaga, Toru, Osawa, Takahiro, Uemura, Motohide, Kimura, Go, Numakura, Kazuyuki, Yamana, Kazutoshi, Miyake, Hideaki, Fukasawa, Satoshi, Ochi, Kenya, Kaneko, Hirokazu, Uemura, Hirotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392942/
https://www.ncbi.nlm.nih.gov/pubmed/32519026
http://dx.doi.org/10.1007/s10147-020-01692-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392942/
https://www.ncbi.nlm.nih.gov/pubmed/32519026
http://dx.doi.org/10.1007/s10147-020-01692-z

Ejemplares similares